Market Place
Sourcing Support
Clinical Data On Salarius’ Seclidemstat In MDS And CMML Presented At EHA 2024
17 Jun 2024 //
GLOBENEWSWIRE
Salarius Provides Update on Review Process to Support Seclidemstat Trials
22 Feb 2024 //
GLOBENEWSWIRE
Investigator-initiated Phase 1/2 Clinical Trial Using Salarius` Seclidemstat to Treat Hematologic Cancers
03 Jan 2024 //
GLOBENEWSWIRE
Salarius Completes FDA Meeting for Seclidemstat Sarcoma Development Program
07 Nov 2023 //
GLOBENEWSWIRE
FDA frees Salarius’ rare cancer asset from clinical hold
10 May 2023 //
FIERCE BIOTECH
Salarius to Present In Vitro Data on Seclidemstat in Small Cell Lung Cancer
07 Mar 2023 //
GLOBENEWSWIRE
Investigators Present Data on Salarius’s Seclidemstat at ASH
13 Dec 2022 //
GLOBENEWSWIRE
Salarius Pharma Announces Interim Results from Phase 1/2 Trial of Seclidemstat
01 Dec 2022 //
GLOBENEWSWIRE
Salarius Announces Pause in Patient Enrollment in Ph1/2 Trial of Seclidemstat
19 Oct 2022 //
PRESS RELEASE
Salarius Adds 2 Mayo Clinic Sites to Ongoing Phase 1/2 Trial of Seclidemstat
22 Aug 2022 //
GLOBENEWSWIRE
Salarius Pharmaceuticals and Fox Chase Cancer Center Launch Research Partnership
22 Sep 2021 //
GLOBENEWSWIRE
Salarius Announces New Clinical Trial to Study Seclidemstat
15 Jun 2021 //
GLOBENEWSWIRE
Salarius Initiates Expansion Stage of Phase 1/2 Clinical Trial
24 Feb 2021 //
GLOBENEWSWIRE
Salarius Pharmaceuticals to Present Trial in Progress Poster at ASCO20
27 May 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.